The design of the proton therapy center being constructed at the University of Pennsylvania is based on several principles that distinguish it from other proton facilities. Among these principles is the recognition that advances in imaging, and particularly in functional imaging, will have a large impact on radiotherapy in the near future and that the conformation of proton dose distributions can utilize that information to a larger degree than other treatment techniques. The facility will contain four-dimensional CT-simulators, an MR-simulator capable of spectroscopy, and a PET-CT scanner.
Introduction
In the mid-1990s the Department of Radiation Oncology at the University of Pennsylvania began investigating the possibility of building a proton therapy facility. The interest was initiated by the successful hospital-based proton therapy program at Loma Linda University Medical Center (LLUMC) and the com- Massachusetts General Hospital (MGH) to move their program from the Harvard Cyclotron Laboratory onto the hospital campus. The idea of a proton therapy facility that was integrated with the hospital was very appealing to the Penn faculty.
As often happens with projects that require significant capital investment, it took a long time to get approval for the project. At least three requests-for-proposal were extended over the following decade, multiple potential partners were considered, and three different building were designed. Six vendors responded with proposals. Most of the vendors responded to each request. Finally, in June 2006 a contract was signed with Ion Beam Applications, SA (IBA) to build the facility. Included in this contract were agreements with IBA and Varian Medical Systems for three developments of new technologies that we considered critical to our facility. They were related to: (i) the design of a multileaf collimator; (ii) the adaptation of cone-beam CT (CBCT) to the proton gantries; and (iii) the use of magnetically scanned proton beams to replace the traditional scattered delivery for some treatments.
Part of the cost to develop these technologies is being funded by the federal government and the development is in collaboration with the radiation therapy group at Walter Reed Army Medical Center (WRAMC). In addition to these projects the collaboration will implement a method for the radiation oncologists at WRAMC to participate in the treatment planning of their patients who receive proton therapy at the new facility.
The following sections will describe the philosophy behind the design of the facility and the resulting plan.
Methods

Imaging
During the decade that it took to receive approval to build the facility, one constant goal was that the result would be an integrated, state-of-the-art proton facility that possessed the most advanced imaging capabilities available. We recognized that the improvements in imaging technologies perfectly complemented the advantage that proton therapy has over other radiation treatments, which is its ability to best conform the dose to a specified target. With the improvements in imaging we now have the ability to better define the targets, and with advances applied in conventional radiotherapy, we can better position patients during their treatments.
Positron Emission Tomography (PET) and Magnetic Resonance (MR) spectroscopy are two developments that are used increasingly to define target volumes because of the nature of the images they provide. The images obtained show not only the anatomy, they also contain information that indicates what the cells are doing. The most common PET protocols detect regions of high metabolic activity that potentially indicate areas of malignancy, while MR spectroscopy can detect specific molecules that tend to be more common in cancerous cells.
Another recent advance in imaging is the multislice CT scanner that can quickly provide multiple images of the same area. Multiple images that are acquired at different times can be reconstructed to show the change in anatomy with time, sometimes called four-dimensional CT. When such a CT is used in radiotherapy treatment planning in conjunction with the ability to gate the treatment; i.e., turn the beam off under specified conditions, the treatment volume can be reduced because one no longer needs the margin allowed for the uncertainty in the position of the tumor. The advantages derived from this capability are largest when the target is near the diaphragm, including most lung treatments and many abdominal treatments.
Efficiency
Because of the large capital investment to build a proton facility, a second consistent objective was to use the beam and treatment rooms efficiently. After visiting several existing facilities, particularly the hospital-based centers at LLUMC and MGH, we identified several features that we wanted included in our plans. Some of the features were positive, so we wanted to duplicate those, but some were negative. In the latter cases we decided that our facility needed to be designed from the start to eliminate those inefficiencies.
We clearly wanted to reduce the number of apertures used. We decided that an MLC would be necessary to replace custom-made apertures. The apertures present multiple problems because they need to be machined prior to treatment, stored during treatment, and stored for several months after treatment due to activation. They could be very heavy, thus requiring specialized staff to assist the radiation therapy technologists. In some vendors' systems a "snout," weighing hundreds of pounds, would have to be changed by using a crane between patient treatments that used large fields and small fields.
A second method to reduce apertures was to use the scanning delivery method when appropriate. With this method the dose deposition is controlled by using magnets to sweep the proton beam across the target; no apertures are required. There are other advantages to this approach, and we wanted the capability to quickly switch from one delivery method to the other -the so-called "universal nozzle." Of course, eliminating apertures and using universal nozzles can only save time if the scanned beam can be delivered quickly, so that became a requirement. 
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The time to deliver a treatment and for the beam to switch from one room to another becomes more important as the number of treatment rooms increases. We specified that a dose of 2 Gy was to be delivered in one minute and that the time to switch the beam from one room to another was to be less than 15 seconds. The treatment time requirement is not much different than at LLUMC or MGH, but the switching time is approximately four times faster. We considered the switching time to be wasted beam and reduced it as much as possible without significantly increasing the cost of the power supplies and magnets. A development project, related to the fast switching time, is underway that will determine how the beam can be used most efficiently.
As another time-saving development, we specified that the facility was to have a "setup" room consisting of a simulator and all of the localization equipment included in the proton treatment rooms. The intention is to bring patients to this room prior to the first treatment, to verify that they can be positioned in the same way as during the CT-simulation on which the treatment plan was based. Verification imaging would still be done in the treatment rooms; this step is meant to identify cases where there are problems with a setup without occupying the treatment room.
Telemedicine and Protocol Development
We expect that many of the patients treated in the proton facility will receive much of their care, including the treatment planning, at sites away from the University of Pennsylvania. This fact presents difficulties in several areas, from ensuring that similar methods are used for the conventional parts of a treatment to providing a secure method to transfer the patient data between collaborating sites. The security of the computer network is most challenging when dealing with our colleagues at Walter Reed Army Medical Center (WRAMC) because their internal network is part of the Department of Defense network, which has strict limitations on its use.
Part of the funding for the facility comes from the federal government, with the expectation that WRAMC will be able to offer their patients proton therapy when appropriate.
With their counterparts at Penn, physicians and other staff at WRAMC will discuss cases at joint tumor boards, and if a patient is to be treated with protons, the WRAMC staff will perform the immobilization, simulation, and treatment planning steps. The steps that require exchange of information from the WRAMC network to the proton network occur during the initial discussion of the patient; during the planning process, when the RT-plan gets transferred to the proton record-and-verify system; and during and possibly after the treatment so the involved physicians can keep apprised of the patient's status.
Discussion
Department Design
The integrated department design consists of 140,000 square feet, of which approximately 120,000 square feet on a single floor make up the clinical area, with the remainder used as offices located in another part of the building. The clinical area will have four conventional linear accelerators, two multislice CT-simulators, a 1.5T MRI, a PET-CT, two conventional simulators that can be used as setup rooms, a high-dose-rate brachytherapy system, and capacity for sixteen treatment planning stations. There will be a dedicated area for children with a separate waiting room, nursing station, and exam rooms.
The proton area will have four rooms with gantries, one fixed beam room, and a research room with two fixed beam lines. Two of the gantry rooms will have universal nozzles that are capable of delivering single and double scattered modes, uniform scanning, and pencil-beam scanning. The other two gantry rooms will initially not have the pencilbeam scanning mode but will have the other three modes. Each gantry room will use an MLC to shape the scattered beams and have the capacity to have two boluses mounted so that two fields could be treated without the need to enter the room between fields. The fixed beam treatment room will have a dedicated pencil beam scanning nozzle.
Beam gating will be possible in all conventional and proton treatment rooms and, initially, CBCT will be available in all of the conventional rooms and three of the proton gantry rooms. Localization using x-ray imaging and infrared camera systems viewing bite-blocks or ultrasound devices will available in all rooms. This is an area where there is much development in conventional radiotherapy, so new technology for localization will be evaluated as it becomes available.
Development
In some cases the equipment that will be installed in the facility does not yet exist and, in other cases, the optimal use of the equipment or methods is still being refined. In both areas Penn and WRAMC are working to develop the new devices or applications. An example of equipment development is the MLC for proton beams. We are working with IBA and Varian, which has vast experience with MLCs in conventional radiotherapy, to design the proton MLC. Among the many design issues are:
(i) what MLC material will minimize the dose to technologists and dose to the patient outside the treatment field; (ii) what leaf dimensions present the best balance between dose distribution and cost;
(iii) what electronics should be used to assure its survival in a high radiation field; and (iv) how can the MLC be designed to permit the device to get as close to the patient as possible, thus providing the sharpest dose distribution. Scanned beams provide an example where techniques must be developed to measure the dose distribution of a moving beam and to account for organ motion or inhomogeneities that may change over time. Both Penn and WRAMC are using Monte Carlo programs that simulate the proton beam in patients to better understand these effects. The feature that makes proton beams so desirable for radiotherapy -the Bragg peak with its sharp falloff -makes the dose deposited by proton beams much more sensitive to path length; accordingly, changes of that length must be taken into account.
Another area of on-going development is in defining the clinical protocols under which patients will be treated. Until recently only MGH and LLUMC treated enough patients for clinical studies to be considered. As more high-volume facilities come on line there will be more opportunities to enroll patients in clinical trials. To that end Penn and WRAMC physicians are working with the physicians at other proton centers to develop protocols. Additionally they must develop the communication methods (tumor boards, chart rounds, etc.) and the technology to support them.
We plan to use a virtual private network (VPN) to connect WRAMC computers, which are not on the DOD network, to the Penn network. This will permit the approved WRAMC staff access to the patient data in all of the above instances except one. The initial step of introducing the patient's imaging data into the proton system will have to be done manually since it initially resides on WRAMC computers that cannot connect to the VPN. We currently plan to use Internet-2, a high-speed network that parallels the traditional internet, to connect WRAMC to Penn and expect that its high bandwidth will allow interactive videoconferencing along with sharing of the desktop applications such as treatment planning.
Conclusion
The Roberts Proton Therapy Center currently under construction at the University of Pennsylvania will be the largest and most technologically advanced proton facility in the United States. Faculty from Penn and WRAMC are working to develop the necessary technology and techniques along with our industrial partners, IBA and Varian. The facility is expected to treat its first patient in 2009.
